RAM
LTRN icon

Redmond Asset Management’s Lantern Pharma LTRN Stock Holding History

Redmond Asset Management’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-37,270
Closed -$119K – 209
2024
Q4 		$119K Sell
37,270
-1,650
-4% -$5.65K 0.03% 201
2024
Q3 		$143K Sell
38,920
-715
-2% -$2.94K 0.04% 150
2024
Q2 		$185K Sell
39,635
-827
-2% -$4.97K 0.06% 151
2024
Q1 		$356K Sell
40,462
-200
-0.5% -$1.07K 0.11% 132
2023
Q4 		$174K Sell
40,662
-5,844
-13% -$20.6K 0.06% 154
2023
Q3 		$159K Sell
46,506
-98
-0.2% -$445 0.06% 156
2023
Q2 		$263K Sell
46,604
-2,585
-5% -$13.4K 0.09% 147
2023
Q1 		$238K Sell
49,189
-1,184
-2% -$6.22K 0.08% 151
2022
Q4 		$304K Buy
50,373
+871
+2% +$4.36K 0.11% 146
2022
Q3 		$237K Sell
49,502
-162
-0.3% -$871 0.09% 155
2022
Q2 		$284K Sell
49,664
-129
-0.3% -$769 0.1% 160
2022
Q1 		$356K Buy
49,793
+606
+1% +$4.05K 0.11% 162
2021
Q4 		$393K Buy
49,187
+1,745
+4% +$15.9K 0.11% 167
2021
Q3 		$530K Buy
47,442
+1,942
+4% +$25.1K 0.17% 147
2021
Q2 		$664K Buy
45,500
+509
+1% +$7.86K 0.19% 141
2021
Q1 		$816K Buy
+44,991
New +$789K 0.25% 127

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Redmond Asset Management's LTRN Position: Q1 2025 in Review

Redmond Asset Management sold out of Lantern Pharma (LTRN) in Q1 2025, closing a stake of 37,270 shares — an estimated $119K sold.

Redmond Asset Management first reported a position in LTRN in Q1 2021 and held it in 16 quarters. The position peaked at $816K in Q1 2021. 32 funds tracked by Wall St. Rank hold LTRN as of Q1 2025.

  • Redmond Asset Management reported no remaining Lantern Pharma position as of Q1 2025 after selling out during the quarter.
  • Redmond Asset Management sold 37,270 Lantern Pharma shares in Q1 2025, an estimated $119K.
  • Redmond Asset Management first reported a position in Lantern Pharma in Q1 2021 and held it in 16 quarters.
  • Redmond Asset Management's Lantern Pharma position peaked at $816K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2025.

Based on Redmond Asset Management's 13F filing for Q1 2025, filed 13 May 2025.